Sunitinib in patients with metastatic renal cell carcinoma of intermediate and high risk groups – Lithuanian National Cancer Institute retrospective analysis - V. Urbonas; A. Zalimas; D. Dabkeviciene; A. Ulys; A. Matulevicius; F. Jankevicius; S. Jarmalaite (European Urology Open Science, 2020)